[Acetylsalicylic acid in the primary and secondary prevention of vascular disease]

Internist (Berl). 2010 Oct;51(10):1330, 1332. doi: 10.1007/s00108-010-2723-1.

[Article in German]

Authors

K Schrör¹, S Nitschmann

Affiliation

¹ Institut für Pharmakologie und Klinische Pharmakologie, UniversitätsKlinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Deutschland. [email protected]

PMID: 20725706
DOI: 10.1007/s00108-010-2723-1

No abstract available

Publication types

Meta-Analysis

MeSH terms

Aspirin / adverse effects
Aspirin / therapeutic use*
Cerebral Hemorrhage / chemically induced
Cerebral Hemorrhage / mortality
Germany
Hemorrhage / chemically induced
Hemorrhage / mortality
Humans
Myocardial Infarction / mortality
Myocardial Infarction / prevention & control*
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Secondary Prevention
Stroke / mortality
Stroke / prevention & control*
Survival Rate
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Aspirin